{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T18:01:23Z","timestamp":1791396083247,"version":"4.3.3"},"reference-count":109,"publisher":"Informa UK Limited","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cell Cycle"],"published-print":{"date-parts":[[2013,4,15]]},"DOI":"10.4161\/cc.24479","type":"journal-article","created":{"date-parts":[[2013,4,12]],"date-time":"2013-04-12T16:33:48Z","timestamp":1365784428000},"page":"1166-1179","source":"Crossref","is-referenced-by-count":154,"title":["The Warburg effect version 2.0: Metabolic reprogramming of cancer stem cells"],"prefix":"10.1080","volume":"12","author":[{"given":"JAVIER","family":"MENENDEZ","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge","family":"Joven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00cdLVIA","family":"CUF\u00cd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"BRUNA","family":"COROMINAS-FAJA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Oliveras-Ferraros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ELISABET","family":"CUY\u00c0S","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bego\u00f1a","family":"Martin-Castillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugeni","family":"L\u00f3pez-Bonet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"TOM\u00c1S","family":"ALARC\u00d3N","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandro","family":"Vazquez-Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2014,10,28]]},"reference":[{"key":"R1","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1126\/science.1204040","article-title":"Exploring the genomes of cancer cells: progress and promise","volume":"331","author":"Stratton","year":"2011","journal-title":"Science"},{"key":"R2","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/nbt.2284","article-title":"Combinatorial drug therapy for cancer in the post-genomic era","volume":"30","author":"Al-Lazikani","year":"2012","journal-title":"Nat Biotechnol"},{"key":"R3","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/nrd3913","article-title":"Objective assessment of cancer genes for drug discovery","volume":"12","author":"Patel","year":"2013","journal-title":"Nat Rev Drug Discov"},{"key":"R4","unstructured":"http:\/\/www.who.int\/mediacentre\/factsheets\/fs297\/en\/index.html"},{"key":"R5","unstructured":"http:\/\/www.fda.gov\/scienceresearch\/specialtopics\/criticalpathinitiative\/default.htm"},{"key":"R6","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1126\/science.296.5568.698","article-title":"Complex disease and the new clinical sciences","volume":"296","author":"Rees","year":"2002","journal-title":"Science"},{"key":"R7","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/nature05610","article-title":"Patterns of somatic mutation in human cancer genomes","volume":"446","author":"Greenman","year":"2007","journal-title":"Nature"},{"key":"R8","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1126\/science.1133427","article-title":"The consensus coding sequences of human breast and colorectal cancers","volume":"314","author":"Sj\u00f6blom","year":"2006","journal-title":"Science"},{"key":"R9","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1126\/science.1145720","article-title":"The genomic landscapes of human breast and colorectal cancers","volume":"318","author":"Wood","year":"2007","journal-title":"Science"},{"key":"R10","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1038\/nature07943","article-title":"The cancer genome","volume":"458","author":"Stratton","year":"2009","journal-title":"Nature"},{"key":"R11","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1038\/nature10983","article-title":"The genomic and transcriptomic architecture of 2,000 breast tumors reveals novel subgroups","volume":"486","author":"Curtis","year":"2012","journal-title":"Nature"},{"key":"R12","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1038\/464972a","article-title":"Big science: The cancer genome challenge","volume":"464","author":"Ledford","year":"2010","journal-title":"Nature"},{"key":"R13","doi-asserted-by":"crossref","first-page":"5219","DOI":"10.1200\/JCO.2009.27.4944","article-title":"Clinical implications of the cancer genome","volume":"28","author":"Macconaill","year":"2010","journal-title":"J Clin Oncol"},{"key":"R14","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1038\/nm.2323","article-title":"Cancer genomics: from discovery science to personalized medicine","volume":"17","author":"Chin","year":"2011","journal-title":"Nat Med"},{"key":"R15","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1158\/1078-0432.CCR-11-2019","article-title":"Impact of genomics on personalized cancer medicine","volume":"18","author":"Arteaga","year":"2012","journal-title":"Clin Cancer Res"},{"key":"R16","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1007\/s10585-012-9483-3","article-title":"Molecular profiling for personalized cancer care","volume":"29","author":"Ashfaq","year":"2012","journal-title":"Clin Exp Metastasis"},{"key":"R17","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1158\/0008-5472.CAN-05-3153","article-title":"Cancer stem cells: an old idea--a paradigm shift","volume":"66","author":"Wicha","year":"2006","journal-title":"Cancer Res"},{"key":"R18","doi-asserted-by":"crossref","first-page":"3983","DOI":"10.1073\/pnas.0530291100","article-title":"Prospective identification of tumorigenic breast cancer cells","volume":"100","author":"Al-Hajj","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"R19","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1093\/jnci\/djn123","article-title":"Intrinsic resistance of tumorigenic breast cancer cells to chemotherapy","volume":"100","author":"Li","year":"2008","journal-title":"J Natl Cancer Inst"},{"key":"R20","doi-asserted-by":"crossref","first-page":"13820","DOI":"10.1073\/pnas.0905718106","article-title":"Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features","volume":"106","author":"Creighton","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"key":"R21","doi-asserted-by":"crossref","first-page":"2813","DOI":"10.1200\/JCO.2008.16.3931","article-title":"Implications of the cancer stem-cell hypothesis for breast cancer prevention and therapy","volume":"26","author":"Kakarala","year":"2008","journal-title":"J Clin Oncol"},{"key":"R22","doi-asserted-by":"crossref","first-page":"4006","DOI":"10.1200\/JCO.2009.27.5388","article-title":"Targeting breast cancer stem cells","volume":"28","author":"Liu","year":"2010","journal-title":"J Clin Oncol"},{"key":"R23","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/bcr1021","article-title":"Mammary stem cells, self-renewal pathways, and carcinogenesis","volume":"7","author":"Liu","year":"2005","journal-title":"Breast Cancer Res"},{"key":"R24","doi-asserted-by":"crossref","first-page":"2813","DOI":"10.1200\/JCO.2008.16.3931","article-title":"Implications of the cancer stem-cell hypothesis for breast cancer prevention and therapy","volume":"26","author":"Kakarala","year":"2008","journal-title":"J Clin Oncol"},{"key":"R25","doi-asserted-by":"crossref","first-page":"2357","DOI":"10.1242\/jcs.054296","article-title":"Stem cells in cancer: instigators and propagators?","volume":"123","author":"Alison","year":"2010","journal-title":"J Cell Sci"},{"key":"R26","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1158\/1940-6207.CAPR-10-0234","article-title":"The origins and implications of intratumor heterogeneity","volume":"3","author":"Michor","year":"2010","journal-title":"Cancer Prev Res (Phila)"},{"key":"R27","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1002\/path.2793","article-title":"Cancer stem cells: problems for therapy?","volume":"223","author":"Alison","year":"2011","journal-title":"J Pathol"},{"key":"R28","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.ccr.2012.03.003","article-title":"Cancer stem cells: impact, heterogeneity, and uncertainty","volume":"21","author":"Magee","year":"2012","journal-title":"Cancer Cell"},{"key":"R29","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/j.cell.2008.03.027","article-title":"The epithelial-mesenchymal transition generates cells with properties of stem cells","volume":"133","author":"Mani","year":"2008","journal-title":"Cell"},{"key":"R30","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.cell.2009.10.014","article-title":"An epigenetic switch involving NF-kappaB, Lin28, Let-7 MicroRNA, and IL6 links inflammation to cell transformation","volume":"139","author":"Iliopoulos","year":"2009","journal-title":"Cell"},{"key":"R31","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.cell.2011.07.026","article-title":"Stochastic state transitions give rise to phenotypic equilibrium in populations of cancer cells","volume":"146","author":"Gupta","year":"2011","journal-title":"Cell"},{"key":"R32","doi-asserted-by":"crossref","first-page":"7950","DOI":"10.1073\/pnas.1102454108","article-title":"Normal and neoplastic nonstem cells can spontaneously convert to a stem-like state","volume":"108","author":"Chaffer","year":"2011","journal-title":"Proc Natl Acad Sci USA"},{"key":"R33","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1073\/pnas.1018898108","article-title":"Inducible formation of breast cancer stem cells and their dynamic equilibrium with non-stem cancer cells via IL6 secretion","volume":"108","author":"Iliopoulos","year":"2011","journal-title":"Proc Natl Acad Sci USA"},{"key":"R34","doi-asserted-by":"crossref","first-page":"14470","DOI":"10.1073\/pnas.1212811109","article-title":"An integrated transcriptional regulatory circuit that reinforces the breast cancer stem cell state","volume":"109","author":"Polytarchou","year":"2012","journal-title":"Proc Natl Acad Sci USA"},{"key":"R35","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.molmed.2012.06.005","article-title":"Hallmarks of cancer: of all cancer cells, all the time?","volume":"18","author":"Floor","year":"2012","journal-title":"Trends Mol Med"},{"key":"R36","first-page":"309","article-title":"Uber den stoffwechsel der carcinomzelle","volume":"152","author":"Warburg","year":"1924","journal-title":"Biochem Z"},{"key":"R37","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1126\/science.123.3191.309","article-title":"On the origin of cancer cells","volume":"123","author":"Warburg","year":"1956","journal-title":"Science"},{"key":"R38","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/s10549-010-0924-x","article-title":"The anti-diabetic drug metformin suppresses self-renewal and proliferation of trastuzumab-resistant tumor-initiating breast cancer stem cells","volume":"126","author":"Vazquez-Martin","year":"2011","journal-title":"Breast Cancer Res Treat"},{"key":"R39","doi-asserted-by":"crossref","first-page":"674","DOI":"10.2174\/156652410792630625","article-title":"Metformin and energy metabolism in breast cancer: from insulin physiology to tumor-initiating stem cells","volume":"10","author":"Vazquez-Martin","year":"2010","journal-title":"Curr Mol Med"},{"key":"R40","doi-asserted-by":"crossref","first-page":"3807","DOI":"10.4161\/cc.9.18.13131","article-title":"Metformin regulates breast cancer stem cell ontogeny by transcriptional regulation of the epithelial-mesenchymal transition (EMT) status","volume":"9","author":"Vazquez-Martin","year":"2010","journal-title":"Cell Cycle"},{"key":"R41","doi-asserted-by":"crossref","first-page":"4461","DOI":"10.4161\/cc.9.22.14048","article-title":"Metformin against TGF\u03b2-induced epithelial-to-mesenchymal transition (EMT): from cancer stem cells to aging-associated fibrosis","volume":"9","author":"Cuf\u00ed","year":"2010","journal-title":"Cell Cycle"},{"key":"R42","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.4161\/cc.10.7.15210","article-title":"Micro(mi)RNA expression profile of breast cancer epithelial cells treated with the anti-diabetic drug metformin: induction of the tumor suppressor miRNA let-7a and suppression of the TGF\u03b2-induced oncomiR miRNA-181a","volume":"10","author":"Oliveras-Ferraros","year":"2011","journal-title":"Cell Cycle"},{"key":"R43","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.drup.2011.04.003","article-title":"Repositioning chloroquine and metformin to eliminate cancer stem cell traits in pre-malignant lesions","volume":"14","author":"Vazquez-Martin","year":"2011","journal-title":"Drug Resist Updat"},{"key":"R44","doi-asserted-by":"crossref","first-page":"3658","DOI":"10.4161\/cc.10.21.18128","article-title":"mTOR-regulated senescence and autophagy during reprogramming of somatic cells to pluripotency: a roadmap from energy metabolism to stem cell renewal and aging","volume":"10","author":"Menendez","year":"2011","journal-title":"Cell Cycle"},{"key":"R45","doi-asserted-by":"crossref","first-page":"974","DOI":"10.4161\/cc.11.5.19450","article-title":"Activation of AMP-activated protein kinase (AMPK) provides a metabolic barrier to reprogramming somatic cells into stem cells","volume":"11","author":"Vazquez-Martin","year":"2012","journal-title":"Cell Cycle"},{"key":"R46","doi-asserted-by":"crossref","first-page":"393","DOI":"10.18632\/aging.100465","article-title":"Mitochondrial fusion by pharmacological manipulation impedes somatic cell reprogramming to pluripotency: new insight into the role of mitophagy in cell stemness","volume":"4","author":"Vazquez-Martin","year":"2012","journal-title":"Aging (Albany NY)"},{"key":"R47","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1038\/srep00964","article-title":"Metformin limits the tumorigenicity of iPS cells without affecting their pluripotency","volume":"2","author":"Vazquez-Martin","year":"2012","journal-title":"Sci Rep"},{"key":"R48","doi-asserted-by":"crossref","first-page":"207","DOI":"10.4161\/cc.23352","article-title":"The mitochondrial H(+)-ATP synthase and the lipogenic switch: new core components of metabolic reprogramming in induced pluripotent stem (iPS) cells","volume":"12","author":"Vazquez-Martin","year":"2013","journal-title":"Cell Cycle"},{"key":"R49","unstructured":"http:\/\/www.cnio.es\/es\/news\/docs\/tak-mak-cnio-1jun12-en.pdf"},{"key":"R50","unstructured":"http:\/\/utmj.org\/ojs\/index.php\/UTMJ\/article\/viewFile\/1265\/1143"},{"key":"R51","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0092-8674(00)81683-9","article-title":"The hallmarks of cancer","volume":"100","author":"Hanahan","year":"2000","journal-title":"Cell"},{"key":"R52","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1038\/nrc1478","article-title":"Why do cancers have high aerobic glycolysis?","volume":"4","author":"Gatenby","year":"2004","journal-title":"Nat Rev Cancer"},{"key":"R53","doi-asserted-by":"crossref","first-page":"5216","DOI":"10.1158\/0008-5472.CAN-05-4193","article-title":"Acid-mediated tumor invasion: a multidisciplinary study","volume":"66","author":"Gatenby","year":"2006","journal-title":"Cancer Res"},{"key":"R54","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1038\/nrc2892","article-title":"Evolutionary dynamics of cancer prevention","volume":"10","author":"Gatenby","year":"2010","journal-title":"Nat Rev Cancer"},{"key":"R55","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1158\/0008-5472.CAN-12-2796","article-title":"Acidity generated by the tumor microenvironment drives local invasion","volume":"73","author":"Estrella","year":"2013","journal-title":"Cancer Res"},{"key":"R56","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1126\/science.1160809","article-title":"Understanding the Warburg effect: the metabolic requirements of cell proliferation","volume":"324","author":"Vander Heiden","year":"2009","journal-title":"Science"},{"key":"R57","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.cmet.2007.10.002","article-title":"The biology of cancer: metabolic reprogramming fuels cell growth and proliferation","volume":"7","author":"DeBerardinis","year":"2008","journal-title":"Cell Metab"},{"key":"R58","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1101\/gad.1756509","article-title":"Tumor suppressors and cell metabolism: a recipe for cancer growth","volume":"23","author":"Jones","year":"2009","journal-title":"Genes Dev"},{"key":"R59","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1101\/sqb.2012.76.010496","article-title":"Rethinking the regulation of cellular metabolism","volume":"76","author":"Thompson","year":"2011","journal-title":"Cold Spring Harb Symp Quant Biol"},{"key":"R60","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.semcdb.2012.02.002","article-title":"Metabolic reprogramming in cancer: unraveling the role of glutamine in tumorigenesis","volume":"23","author":"Daye","year":"2012","journal-title":"Semin Cell Dev Biol"},{"key":"R61","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.ccr.2008.05.005","article-title":"Tumor cell metabolism: cancer\u2019s Achilles\u2019 heel","volume":"13","author":"Kroemer","year":"2008","journal-title":"Cancer Cell"},{"key":"R62","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"R63","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1038\/nm1087","article-title":"Cancer genes and the pathways they control","volume":"10","author":"Vogelstein","year":"2004","journal-title":"Nat Med"},{"key":"R64","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.cell.2010.10.008","article-title":"Pluripotency and cellular reprogramming: facts, hypotheses, unresolved issues","volume":"143","author":"Hanna","year":"2010","journal-title":"Cell"},{"key":"R65","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1038\/cr.2011.28","article-title":"Reprogramming to pluripotency: stepwise resetting of the epigenetic landscape","volume":"21","author":"Papp","year":"2011","journal-title":"Cell Res"},{"key":"R66","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.stem.2011.11.003","article-title":"Reprogramming factor stoichiometry influences the epigenetic state and biological properties of induced pluripotent stem cells","volume":"9","author":"Carey","year":"2011","journal-title":"Cell Stem Cell"},{"key":"R67","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0065-230X(08)00005-5","article-title":"The tumorigenicity of human embryonic stem cells","volume":"100","author":"Blum","year":"2008","journal-title":"Adv Cancer Res"},{"key":"R68","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1002\/stem.37","article-title":"Deconstructing stem cell tumorigenicity: a roadmap to safe regenerative medicine","volume":"27","author":"Knoepfler","year":"2009","journal-title":"Stem Cells"},{"key":"R69","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1038\/nrc3034","article-title":"The tumorigenicity of human embryonic and induced pluripotent stem cells","volume":"11","author":"Ben-David","year":"2011","journal-title":"Nat Rev Cancer"},{"key":"R70","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.semcancer.2010.02.002","article-title":"Physiological cellular reprogramming and cancer","volume":"20","author":"Abollo-Jim\u00e9nez","year":"2010","journal-title":"Semin Cancer Biol"},{"key":"R71","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.semcancer.2010.02.001","article-title":"Cancer as a reprogramming-like disease: implications in tumor development and treatment","volume":"20","author":"Castellanos","year":"2010","journal-title":"Semin Cancer Biol"},{"key":"R72","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1038\/nature08311","article-title":"Linking the p53 tumor suppressor pathway to somatic cell reprogramming","volume":"460","author":"Kawamura","year":"2009","journal-title":"Nature"},{"key":"R73","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1038\/nature08287","article-title":"A p53-mediated DNA damage response limits reprogramming to ensure iPS cell genomic integrity","volume":"460","author":"Mari\u00f3n","year":"2009","journal-title":"Nature"},{"key":"R74","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1038\/nature08285","article-title":"Immortalization eliminates a roadblock during cellular reprogramming into iPS cells","volume":"460","author":"Utikal","year":"2009","journal-title":"Nature"},{"key":"R75","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1038\/cr.2009.121","article-title":"The role of p53 in limiting somatic cell reprogramming","volume":"19","author":"Liu","year":"2009","journal-title":"Cell Res"},{"key":"R76","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1038\/nature08290","article-title":"The Ink4\/Arf locus is a barrier for iPS cell reprogramming","volume":"460","author":"Li","year":"2009","journal-title":"Nature"},{"key":"R77","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.1101\/gad.1811609","article-title":"Senescence impairs successful reprogramming to pluripotent stem cells","volume":"23","author":"Banito","year":"2009","journal-title":"Genes Dev"},{"key":"R78","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.stem.2009.02.015","article-title":"Mouse fibroblasts lacking RB1 function form spheres and undergo reprogramming to a cancer stem cell phenotype","volume":"4","author":"Liu","year":"2009","journal-title":"Cell Stem Cell"},{"key":"R79","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.cell.2007.07.003","article-title":"Cellular senescence in cancer and aging","volume":"130","author":"Collado","year":"2007","journal-title":"Cell"},{"key":"R80","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/nrc2772","article-title":"Senescence in tumors: evidence from mice and humans","volume":"10","author":"Collado","year":"2010","journal-title":"Nat Rev Cancer"},{"key":"R81","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1038\/nbt.1527","article-title":"The anti-apoptotic gene survivin contributes to teratoma formation by human embryonic stem cells","volume":"27","author":"Blum","year":"2009","journal-title":"Nat Biotechnol"},{"key":"R82","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.stem.2011.07.006","article-title":"Inducing iPSCs to escape the dish","volume":"9","author":"Barrilleaux","year":"2011","journal-title":"Cell Stem Cell"},{"key":"R83","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/j.1474-9726.2011.00754.x","article-title":"Increased dosage of tumor suppressors limits the tumorigenicity of iPS cells without affecting their pluripotency","volume":"11","author":"Menendez","year":"2012","journal-title":"Aging Cell"},{"key":"R84","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1002\/stem.404","article-title":"The senescence-related mitochondrial\/oxidative stress pathway is repressed in human induced pluripotent stem cells","volume":"28","author":"Prigione","year":"2010","journal-title":"Stem Cells"},{"key":"R85","doi-asserted-by":"crossref","first-page":"e20914","DOI":"10.1371\/journal.pone.0020914","article-title":"Energy metabolism in human pluripotent stem cells and their differentiated counterparts","volume":"6","author":"Varum","year":"2011","journal-title":"PLoS ONE"},{"key":"R86","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1002\/stem.683","article-title":"Human induced pluripotent stem cells harbor homoplasmic and heteroplasmic mitochondrial DNA mutations while maintaining human embryonic stem cell-like metabolic reprogramming","volume":"29","author":"Prigione","year":"2011","journal-title":"Stem Cells"},{"key":"R87","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/cr.2011.177","article-title":"The metabolome of induced pluripotent stem cells reveals metabolic changes occurring in somatic cell reprogramming","volume":"22","author":"Panopoulos","year":"2012","journal-title":"Cell Res"},{"key":"R88","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.cmet.2011.06.011","article-title":"Somatic oxidative bioenergetics transitions into pluripotency-dependent glycolysis to facilitate nuclear reprogramming","volume":"14","author":"Folmes","year":"2011","journal-title":"Cell Metab"},{"key":"R89","doi-asserted-by":"crossref","first-page":"715","DOI":"10.2217\/bmm.11.87","article-title":"Energy metabolism in nuclear reprogramming","volume":"5","author":"Folmes","year":"2011","journal-title":"Biomark Med"},{"key":"R90","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1111\/j.1749-6632.2012.06487.x","article-title":"Energy metabolism plasticity enables stemness programs","volume":"1254","author":"Folmes","year":"2012","journal-title":"Ann N Y Acad Sci"},{"key":"R91","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1089\/scd.2012.0375","article-title":"Induced pluripotency and oncogenic transformation are related processes","volume":"22","author":"Riggs","year":"2013","journal-title":"Stem Cells Dev"},{"key":"R92","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1038\/nrc2222","article-title":"Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis","volume":"7","author":"Menendez","year":"2007","journal-title":"Nat Rev Cancer"},{"key":"R93","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1007\/s10549-010-1300-6","article-title":"Resveratrol suppresses growth of cancer stem-like cells by inhibiting fatty acid synthase","volume":"130","author":"Pandey","year":"2011","journal-title":"Breast Cancer Res Treat"},{"key":"R94","doi-asserted-by":"crossref","DOI":"10.1038\/onc.2012.519","article-title":"Elevated lipogenesis in epithelial stem-like cell confers survival advantage in ductal carcinoma in situ of breast cancer","author":"Pandey","year":"2012","journal-title":"Oncogene"},{"key":"R95","first-page":"459","article-title":"Proteomics using mammospheres as a model system to identify proteins deregulated in breast cancer stem cells","volume":"13","author":"Li","year":"2013","journal-title":"Curr Mol Med"},{"key":"R96","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1007\/s12265-012-9431-2","article-title":"Nuclear reprogramming with c-Myc potentiates glycolytic capacity of derived induced pluripotent stem cells","volume":"6","author":"Folmes","year":"2013","journal-title":"J Cardiovasc Transl Res"},{"key":"R97","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s12265-009-9150-5","article-title":"c-MYC independent nuclear reprogramming favors cardiogenic potential of induced pluripotent stem cells","volume":"3","author":"Martinez-Fernandez","year":"2010","journal-title":"J Cardiovasc Transl Res"},{"key":"R98","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1387\/ijdb.103198ap","article-title":"Modulation of mitochondrial biogenesis and bioenergetic metabolism upon in vitro and in vivo differentiation of human ES and iPS cells","volume":"54","author":"Prigione","year":"2010","journal-title":"Int J Dev Biol"},{"key":"R99","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1101\/gad.17420111","article-title":"AMP-activated protein kinase: an energy sensor that regulates all aspects of cell function","volume":"25","author":"Hardie","year":"2011","journal-title":"Genes Dev"},{"key":"R100","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1101\/sqb.2011.76.010819","article-title":"Adenosine monophosphate-activated protein kinase: a central regulator of metabolism with roles in diabetes, cancer, and viral infection","volume":"76","author":"Hardie","year":"2011","journal-title":"Cold Spring Harb Symp Quant Biol"},{"key":"R101","doi-asserted-by":"crossref","first-page":"891S","DOI":"10.3945\/ajcn.110.001925","article-title":"Sensing of energy and nutrients by AMP-activated protein kinase","volume":"93","author":"Hardie","year":"2011","journal-title":"Am J Clin Nutr"},{"key":"R102","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.cmet.2012.12.001","article-title":"AMPK is a negative regulator of the Warburg effect and suppresses tumor growth in vivo","volume":"17","author":"Faubert","year":"2013","journal-title":"Cell Metab"},{"key":"R103","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s10863-007-9087-9","article-title":"A message emerging from development: the repression of mitochondrial beta-F1-ATPase expression in cancer","volume":"39","author":"Cuezva","year":"2007","journal-title":"J Bioenerg Biomembr"},{"key":"R104","doi-asserted-by":"crossref","first-page":"25308","DOI":"10.1074\/jbc.M110.146480","article-title":"Up-regulation of the ATPase inhibitory factor 1 (IF1) of the mitochondrial H+-ATP synthase in human tumors mediates the metabolic shift of cancer cells to a Warburg phenotype","volume":"285","author":"S\u00e1nchez-Cenizo","year":"2010","journal-title":"J Biol Chem"},{"key":"R105","doi-asserted-by":"crossref","first-page":"2963","DOI":"10.4161\/cc.21387","article-title":"IF1 reprograms energy metabolism and signals the oncogenic phenotype in cancer","volume":"11","author":"S\u00e1nchez-Arag\u00f3","year":"2012","journal-title":"Cell Cycle"},{"key":"R106","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1093\/carcin\/bgq012","article-title":"Selection of cancer cells with repressed mitochondria triggers colon cancer progression","volume":"31","author":"S\u00e1nchez-Arag\u00f3","year":"2010","journal-title":"Carcinogenesis"},{"key":"R107","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.bbabio.2010.10.016","article-title":"Post-transcriptional regulation of the mitochondrial H(+)-ATP synthase: a key regulator of the metabolic phenotype in cancer","volume":"1807","author":"Willers","year":"2011","journal-title":"Biochim Biophys Acta"},{"key":"R108","article-title":"Mitochondria-Mediated Energy Adaption in Cancer: The H(+)-ATP Synthase-Geared Switch of Metabolism in Human Tumors","author":"S\u00e1nchez-Arag\u00f3","year":"2012","journal-title":"Antioxid Redox Signal"},{"key":"R109","doi-asserted-by":"crossref","first-page":"3521","DOI":"10.4161\/cc.21878","article-title":"Rejuvenating regeneration: metformin activates endogenous adult stem cells","volume":"11","author":"Menendez","year":"2012","journal-title":"Cell Cycle"}],"container-title":["Cell Cycle"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.tandfonline.com\/doi\/pdf\/10.4161\/cc.24479","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,13]],"date-time":"2022-02-13T17:19:05Z","timestamp":1644772745000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.tandfonline.com\/doi\/abs\/10.4161\/cc.24479"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4,15]]},"references-count":109,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2014,10,28]]},"published-print":{"date-parts":[[2013,4,15]]}},"alternative-id":["10.4161\/cc.24479"],"URL":"https:\/\/doi.org\/10.4161\/cc.24479","relation":{},"ISSN":["1538-4101","1551-4005"],"issn-type":[{"value":"1538-4101","type":"print"},{"value":"1551-4005","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,4,15]]}}}